NCT03879694 2026-02-06Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsRoswell Park Cancer InstitutePhase 1 Completed19 enrolled
NCT02334865 2025-05-11SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance TherapyRoswell Park Cancer InstitutePhase 1 Active not recruiting18 enrolled